Medicines and Healthcare products Regulatory Agency: Disclosure of Information
(asked on 17th June 2026) - View Source
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, with reference to the Answer of 26 March 2026 to Question 122234, what steps were taken in response to those three whistleblowing reports; and whether any procedural, governance and training changes have been implemented as a result.
The following table shows the action taken after each concern was raised, and the outcome:
Concern number | Nature of conflict of interest (COI) | Action | Outcome |
Concern 1 | Alleged non-declaration of a COI | Investigated (human resource procedures) | Upheld |
Concern 2 | Alleged non-declaration of a COI | Taken forward by management and human resources | No investigation required |
Concern 3 | Concern that an investigator lacked impartiality | Considered and responded to | No investigation required |
The Medicines and Healthcare products Regulatory Agency’s Nominated Officers/Fraud Officers have developed a set of slides that they will present to teams later in the year to remind staff and managers of the COI procedures and why they are important, and to disseminate learning from the first two concerns.